Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
135 hedge funds and large institutions have $262M invested in Immunogen Inc in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 32 closing their positions.
91% more capital invested
Capital invested by funds: $137M → $262M (+$125M)
5% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 40
13% less funds holding
Funds holding: 156 → 135 (-21)
30% less call options, than puts
Call options by funds: $760K | Put options by funds: $1.09M
44% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15.6M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$11.6M |
| 3 |
ClearBridge Investments
New York
|
+$2.58M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.15M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$730K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.24M |
| 2 |
Primecap Management
Pasadena,
California
|
-$3.17M |
| 3 |
Renaissance Technologies
New York
|
-$2.93M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.29M |
| 5 |
Two Sigma Investments
New York
|
-$708K |
IMGN Hedge Fund Activity: Q1 2017 in Review
135 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2017, worth a combined $262M — up 91% from $137M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of IMGN and 18 opened new positions — a net loss of 14 holders — while 40 trimmed existing stakes and 38 added.
The largest buyer was BlackRock, adding an estimated $15.6M. The largest seller was Millennium Management, cutting an estimated $3.24M.
- 135 institutional investors held Immunogen Inc (IMGN) as of Q1 2017, down from 156 in Q4 2016.
- Funds reported $262M of Immunogen Inc stock for Q1 2017, up 91% quarter-over-quarter.
- 18 funds opened new Immunogen Inc positions in Q1 2017 and 32 closed out, a net change of -14 holders.
- The largest Immunogen Inc buyer in Q1 2017 was BlackRock, an estimated $15.6M added.
- The largest Immunogen Inc seller in Q1 2017 was Millennium Management, an estimated $3.24M sold.
Based on aggregated 13F filings for Q1 2017.